hero image illustration

i3 STRATEGY PARTNERS

We help you understand and connect with
hard-to-reach patient communities.

Our Three-Point Strategy and Engagement
Platform Delivers:

Achieve Exponential Impact by Reaching More of Your Potential Market

Leverage our knowledge to engage all customer segments and key stakeholders within your total addressable market.

Meet Patients Where They Are and Improve Health Outcomes

Far too many patients get left out of the American health care equation.

We’ve developed unique capabilities for engaging and activating underserviced communities — including Communities of Color, LGBTQ+, rural residents, and other underserviced/overlooked communities whose needs are not always understood or prioritized.

medication icon

A study of 2,180 patients showed that African-American and Native American patients were less likely to be initiated on newer diabetes medications, independent of socioeconomic factors1.

statistics_icon

60 million Americans (about ⅕ of the population) live in rural areas and tend to have more limited access to healthcare2.

A survey of LGBTQ+ populations found 66% felt pharmaceutical marketing did not reflect their experience, and just 33% feel that they can place substantial trust in ads3.

African-American and Hispanic individuals were less likely to take the COVID-19 vaccine than non-Hispanic White individuals, though mortality rates were higher in these populations4.

Strategy-Driven Marketing and Outreach Can Unlock Stronger Connections With Underserviced Communities

By investing time and effort into studying, understanding, and engaging these populations, companies can communicate meaningfully with all patients. This work increases the chances that the total addressable market will be aware of your products and can benefit from them.

Similarly, engaging underserviced populations in clinical trials ensures marketed products can better serve everyone.  Both approaches can help pharmaceutical companies take strides towards making care accessible for all.

Reach out to i3 Strategy Partners to get started

What Can We Do For You?

Our Core Capabilities
From charting diverse patient journeys to ecosystem mapping, our end-to-end micro-targeting approach ensures that your company is knowledgeable of and equipped to engage underserviced communities.

We help you make care accessible so that all communities can thrive.
Patient/Community Insight Discovery

Uncover key insights and develop new strategies to drive business performance while enabling better outcomes for underserviced patient groups.

Community Engagement Planning and Execution

Engage local communities with solutions designed to ensure awareness and access to new therapeutics.

Clinical Trial Recruiting

Bridge the gap in diverse patient recruiting so that efficacy and safety is established for all patient populations.

Differentiators

We Understand the Patient Groups That Deserve a Closer Look

We're redefining inclusive healthcare marketing with a culturally competent, on-the-ground approach.

Deep Pharma Expertise

We are a multi-cultural /
multi-lingual team with deep pharma and life science expertise.

Boots-on-the-Ground

Our Community Engagement Liaisons (CELs) are "on-the-ground", in 7+ underserviced communities across the US.

Community Activation Know-How

We’ve identified 8 essential elements to effectively engaging underserviced patient communities.

Certified by

Go Beyond Insights

Unveil Key Opportunities to Include More Communities

Translate complex healthcare challenges into clear strategies that align business success with social impact.

Discover the Path to
Building Better
Relationships

Actionable Strategies That Deliver Results

From community engagement to technology-driven care models, we ensure your initiatives are effective and sustainable.

Find Connection

Reach Underserviced Patients By Working Collaboratively with the People They Listen to and Trust the Most

Think through and around traditional approaches to discover what makes a difference. Our strategies help you build trust and foster lasting relationships in communities where traditional marketing is often met with skepticism.

Do Well by Doing Good

Inclusive Pharmaceutical Marketing and Health Equity Solutions

Uncover unique ways to produce high-impact strategies, better performance growth, and better outcomes for today's underserved patient population — including BIPOC, LGBTQIA2S+, rural communities, and more.

We deliver inclusive marketing and health equity solutions for pharmaceutical companies and other healthcare product deliverers. Through our research and patient engagement strategies, your organization can deeply engage underserved communities. Our work helps you achieve greater market reach and improve access to an equitable Standard of Care for all populations..

Effectively engaging diverse patients is not only the right thing to do, it is a business imperative.

Do Well by Doing Good

Pharmaceutical Marketing Strategies and Solutions That Care for Every Person

We all need healthcare, but not all of us are considered when cutting edge medications become available. Attempts to reach underserviced populations often miss the mark due to a lack of real insight into the lived experience of people in these communities.

Bring people back into the equation with i3 Strategy Partners. Our solutions enable you to more effectively reach all communities, making them feel seen, heard and valued. This work is designed to create better patient outcomes in underserviced populations while growing your bottom line.

Our Leadership Team

Meet the Experts Behind the Impact

Ann Cunningham

Founder & CEO

Ann Cunningham, Founder and CEO of i³ Strategy Partners, brings over 25 years of experience in the pharmaceutical and biotech industries. She most recently served as Chief Commercial Officer at Vistagen Therapeutics, where she now sits on the Board of Directors. Ann holds a B.A. in Psychology from Yale University and an M.B.A. from the University of Michigan. Her passion for serving underserviced communities was ignited in her early career as a social worker at a county jail. Determined to make a larger impact, Ann leveraged her pharmaceutical expertise, leadership experience, and entrepreneurial spirit to establish i³ Strategy Partners.

Mario Anglada, MBA

Chief Operating Officer

With over 25 years in healthcare as a sales and marketing executive, Mario Anglada has led business units for Fortune 50 organizations such as Procter & Gamble, Johnson and Johnson, Cardinal Health, GF Health, Nestle Health Science, and Univision Communications. Mario is also founder of Hoy Health, a telemedicine company, and a veteran of the US ARMY. Mario has been awarded patents in the USA for digital health solutions focused on underserviced medical communities. In the course of his career, he has leveraged his experience in pharmaceuticals, pharmacy operations, medical devices, medical nutrition, and the Digital Health industry to launch innovative healthcare solutions that expand access to quality care.

Gwen Washington

VP of Commercial Planning

Gwen Washington has over 25 years of experience in pharmaceutical product strategy and marketing for multiple leading pharmaceutical companies. She served as Director of Strategic Consulting and Associate Partner for Magnolia Innovation, a market research consultancy specializing in assisting innovative healthcare companies. Her extensive experience and expertise benefits i³ Strategy Partners and our clients by developing closer relationships between markets and product innovators, helping promote awareness and better access to a higher standard of care.

Ruth Kidane

Director, Strategy & Business Development

Holding a Masters in Public Policy from the University of Virginia and an MBA from the Yale School of Management, Ruth entered the pharmaceutical industry with Pfizer, where she served as a Strategy & Consulting Manager. She also supported Flatiron Health through multiple expansions into Europe and Asia, working primarily from the London office. Leveraging her experience as a freelance Strategy & Operations consultant, Ruth joins us at i³ Strategy Partners and amplifies our expertise in strategy and business development. 

Discover who your key stakeholders are from all sides of your operation

Discover who your key stakeholders are from all sides of your operation. i3 Strategy Partners conducts research, analyses, and extensive mapping for your patients' journeys as well as the care ecosystems that surround them.
Our Core Purpose is to help pharmaceutical companies effectively engage ALL key stakeholders — doctors, payers and patients — especially those who are underserved and overlooked.

A Stakeholder-
Focused Company

Stories of Success:
Hear From Our Partners

Discover how organizations have transformed their approach to achieve greater health equity and better serve diverse patient populations.

Ella Carling
CFO, Genentech

Our Micro-Targeting approach equips leaders to drive growth by meeting diverse patients where they are with solutions to make the Standard of Care accessible to all

Mia Chaplin
CFO, Lily

Our Micro-Targeting approach equips leaders to drive growth by meeting diverse patients where they are with solutions to make the Standard of Care accessible to all

Let's Get to Work, Together

Ready to make an impact?

Reach out to us to discuss how we can help your organization reach more patients in your total addressable market AND make a difference in the effort to close health disparities.

Stay Connected With i3 Strategy

Follow us on social and share our mission with your network.